# clm_7E8E7F35A702

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 1,493,337,000 United States dollar  
valid_from: 2013-06-30  
valid_to: 2013-09-30  
published: 2013-08-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_CF49D665F1F6  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 1,493,337,000 United States dollar", as of 2013-06-30 (until 2013-09-30). Claim clm_7E8E7F35A702, https://asof.is/claim/clm_7E8E7F35A702, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217613000022/0001532176-13-000022-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2013, filed 2013-08-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217613000022/0001532176-13-000022-index.htm (primary, SEC EDGAR 10-Q Q2 FY2013, published 2013-08-06)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 1,406,348,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_7E8E7F35A702](/claim/clm_7E8E7F35A702.md) | [clm_E05AB5ED8875](/claim/clm_E05AB5ED8875.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.